Literature DB >> 1389912

Differentiating agents in cancer therapy.

J Michaeli, R A Rifkind, P A Marks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1389912

Source DB:  PubMed          Journal:  Cancer Chemother Biol Response Modif        ISSN： 0921-4410


× No keyword cloud information.
  2 in total

1.  Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells.

Authors:  D S Siegel; X Zhang; R Feinman; T Teitz; A Zelenetz; V M Richon; R A Rifkind; P A Marks; J Michaeli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

2.  Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells.

Authors:  J Corbeil; E Rapaport; D D Richman; D J Looney
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.